Results 171 to 180 of about 177,118 (275)

Severe allergic reaction to ustekinumab reinitiation in a pediatric patient with Crohn's disease: A case report

open access: yesJPGN Reports, EarlyView.
Abstract Ustekinumab (UST) is a monoclonal antibody used in the management of moderate to severe inflammatory bowel disease. While generally well‐tolerated, serious adverse reactions, including hypersensitivity and anaphylaxis, have been documented, specifical following the initial intravenous (IV) dose.
Kennedy Sparling   +2 more
wiley   +1 more source

NAD+ Enhanced on Hearing Recovery in Sudden Sensorineural Hearing Loss: Randomized Controlled Trial

open access: yesThe Laryngoscope, EarlyView.
This 2‐year, single‐center, double‐blind study with a small sample size compared NAD+ and control groups in a randomized controlled trial for sudden sensorineural hearing loss (SSNHL). Results showed that NAD+ led to better hearing improvement from 7 days to 3 months and a shorter average recovery time compared to the control group.
Minqian Gao   +7 more
wiley   +1 more source

Synchronous Regeneration: Key Mechanism for Selective Reinnervation in Bilateral Vocal Fold Paralysis

open access: yesThe Laryngoscope, EarlyView.
This study investigates the mechanisms behind the success of selective laryngeal reinnervation surgery in bilateral vocal fold paralysis. In an animal model, the surgery promoted neuromuscular regeneration and restored coordinated vocal fold movement, with no misdirected potentials observed.
Meng Li   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy